grant
Improving the Processes around Approval, Accrual and Translational Research in Cancer Prevention Trials
Organization UNIVERSITY OF KANSAS MEDICAL CENTERLocation KANSAS CITY, UNITED STATESPosted 1 Sept 2024Deadline 31 Aug 2029
NIHUS FederalResearch GrantFY2025Antineoplastic VaccineAwardBiological MarkersBrachyuryBrachyury proteinCancer CenterCancer ControlCancer Control Research ProgramCancer Control ScienceCancer Prevention TrialCancer TreatmentCancer VaccinesCancersCaringClinicalClinical TrialsComprehensive Cancer CenterFacultyFamilial Nonpolyposis Colon CancerFundingGI cancersGI malignanciesGI tract cancersGastroenterologistGastrointestinal CancerGastrointestinal Tract CancerGeneralized GrowthGoalsGrowthHNPCCHealthHereditary Colo-rectal Endometrial Cancer SyndromeHereditary Colorectal Endometrial Cancer SyndromeHereditary Defective Mismatch Repair SyndromeHereditary Non-Polyposis Colon CancerHereditary Nonpolyposis Colo-rectal CancerHereditary Nonpolyposis Colo-rectal NeoplasmsHereditary Nonpolyposis Colon CancerHereditary Nonpolyposis Colorectal CancerHereditary Nonpolyposis Colorectal NeoplasmsHomeImageImprove AccessInvestigatorsKansasLS/HNPCCLatinoLeadLynch SyndromeMUC-1MUC1MUC1 gene productMalignant Gastrointestinal NeoplasmMalignant Neoplasm TherapyMalignant Neoplasm TreatmentMalignant NeoplasmsMalignant TumorMalignant neoplasm of gastrointestinal tractMessenger RNAMichiganMinority RecruitmentMuc1 MucinMucin 1Mucin 1 proteinNamesNeoplasm VaccinesOncologyOncology CancerParticipantPathway interactionsPatientsPb elementPhasePhase 2 Clinical TrialsPhase II Clinical TrialsPhysiciansPrevention ResearchPrevention programPrevention trialPrincipal InvestigatorProcessProviderPublishingR-Series Research ProjectsR01 MechanismR01 ProgramResearchResearch GrantsResearch PersonnelResearch Project GrantsResearch ProjectsResearch TrainingResearchersResource SharingRural PopulationRural groupRural peopleScientistStructureT Brachyury proteinTissue GrowthTrainingTranslational ResearchTranslational ScienceTumor VaccinesUniversitiesVaccinesanti-cancer therapyanti-tumor vaccinebio-markersbiologic markerbiomarkercancer preventioncancer therapycancer-directed therapyclinical caregastrointestinal malignanciesheavy metal Pbheavy metal leadhereditary non-polyposis colo-rectal cancerhereditary non-polyposis colorectal cancerhigh risk grouphigh risk individualhigh risk peoplehigh risk populationhomesimagingimprovedmRNAmalignancymembernamenamednamingneoplasm/cancerontogenypathwaypatient populationphase II protocolprocess improvementprogramsrecombinant adenovirusrecruitrecruiting minoritiesretention rateretention strategyrural individualrural under servedrural underservedsuccesstranslation researchtranslational investigationtreatment trialvaccine for cancer
Description preview
ABSTRACT
The central goal of this R50 Clinician Scientist Award application is to establish and refine processes that
facilitate clinical trials in cancer interception at The University of Kansas Cancer Center (KUCC), a unique
goal that is different from the majority of R50 applicants which focus on cancer treatment trials. Cancer…
🔒
Start 7-day free trial — $29.99/mo →Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click